Patents by Inventor Paul Menkin

Paul Menkin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10376587
    Abstract: Disclosed herein are diketopiperazine microparticles having high capacity for adsorbing a drug or active agent. In particular, the diketopiperazine microparticle are formed using fumaryl diketopiperazine and can comprise a drug in large doses for the treatment of disease or disorders by pulmonary delivery via oral inhalation.
    Type: Grant
    Filed: October 4, 2018
    Date of Patent: August 13, 2019
    Assignee: MannKind Corporation
    Inventors: Marshall Grant, Paul Menkin, Grayson W. Stowell
  • Publication number: 20190076530
    Abstract: Disclosed herein are diketopiperazine microparticles having high capacity for adsorbing a drug or active agent. In particular, the diketopiperazine microparticle are formed using fumaryl diketopiperazine and can comprise a drug in large doses for the treatment of disease or disorders by pulmonary delivery via oral inhalation.
    Type: Application
    Filed: October 4, 2018
    Publication date: March 14, 2019
    Inventors: Marshall Grant, Paul Menkin, Grayson W. Stowell
  • Patent number: 10130709
    Abstract: Disclosed herein are diketopiperazine microparticles having high capacity for adsorbing a drug or active agent. In particular, the diketopiperazine microparticle are formed using fumaryl diketopiperazine and can comprise a drug in large doses for the treatment of disease or disorders by pulmonary delivery via oral inhalation.
    Type: Grant
    Filed: May 11, 2016
    Date of Patent: November 20, 2018
    Assignee: MannKind Corporation
    Inventors: Marshall Grant, Paul Menkin, Grayson W. Stowell
  • Publication number: 20170189395
    Abstract: Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2/g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a drug such as insulin.
    Type: Application
    Filed: March 17, 2017
    Publication date: July 6, 2017
    Inventors: Marshall L. Grant, Grayson W. Stowell, Paul Menkin, John J. Freeman, JR.
  • Patent number: 9630930
    Abstract: Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2/g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a drug such as insulin.
    Type: Grant
    Filed: April 11, 2014
    Date of Patent: April 25, 2017
    Assignee: MannKind Corporation
    Inventors: Marshall L. Grant, Grayson W. Stowell, Paul Menkin
  • Publication number: 20160346394
    Abstract: Disclosed herein are diketopiperazine microparticles having high capacity for adsorbing a drug or active agent. In particular, the diketopiperazine microparticle are formed using fumaryl diketopiperazine and can comprise a drug in large doses for the treatment of disease or disorders by pulmonary delivery via oral inhalation.
    Type: Application
    Filed: May 11, 2016
    Publication date: December 1, 2016
    Inventors: Marshall Grant, Paul Menkin, Grayson W. Stowell
  • Patent number: 9364436
    Abstract: Disclosed herein are diketopiperazine microparticles having high capacity for adsorbing a drug or active agent. In particular, the diketopiperazine microparticle are formed using fumaryl diketopiperazine and can comprise a drug in large doses for the treatment of disease or disorders by pulmonary delivery via oral inhalation.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: June 14, 2016
    Assignee: MannKind Corporation
    Inventors: Marshall Grant, Paul Menkin, Grayson W. Stowell
  • Publication number: 20140271888
    Abstract: Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2/g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a drug such as insulin.
    Type: Application
    Filed: April 11, 2014
    Publication date: September 18, 2014
    Applicant: MannKind Corporation
    Inventors: Marshall L. Grant, Grayson W. Stowell, Paul Menkin
  • Publication number: 20140199398
    Abstract: Disclosed herein are diketopiperazine microparticles having high capacity for adsorbing a drug or active agent. In particular, the diketopiperazine microparticle are formed using fumaryl diketopiperazine and can comprise a drug in large doses for the treatment of disease or disorders by pulmonary delivery via oral inhalation.
    Type: Application
    Filed: June 18, 2012
    Publication date: July 17, 2014
    Applicant: MANNKIND CORPORATION
    Inventors: Marshall Grant, Paul Menkin, Grayson W. Stowell
  • Patent number: 8778403
    Abstract: Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2/g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a drug such as insulin.
    Type: Grant
    Filed: September 3, 2013
    Date of Patent: July 15, 2014
    Assignee: Mannkind Corporation
    Inventors: Marshall L. Grant, Grayson W. Stowell, Paul Menkin
  • Patent number: 8734845
    Abstract: Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2/g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a drug such as insulin.
    Type: Grant
    Filed: June 11, 2010
    Date of Patent: May 27, 2014
    Assignee: Mannkind Corporation
    Inventors: Marshall L. Grant, Grayson W. Stowell, Paul Menkin
  • Publication number: 20140045745
    Abstract: Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2/g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a drug such as insulin.
    Type: Application
    Filed: September 3, 2013
    Publication date: February 13, 2014
    Applicant: MannKind Corporation
    Inventors: Marshall L. Grant, Grayson W. Stowell, Paul Menkin
  • Patent number: 8551528
    Abstract: Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2/g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a drug such as insulin.
    Type: Grant
    Filed: June 11, 2010
    Date of Patent: October 8, 2013
    Assignee: Mannkind Corporation
    Inventors: Marshall L. Grant, Grayson W. Stowell, Paul Menkin
  • Publication number: 20120164186
    Abstract: Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2/g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a drug such as insulin.
    Type: Application
    Filed: June 11, 2010
    Publication date: June 28, 2012
    Applicant: MANNKIND CORPORATION
    Inventors: Marshall L. Grant, Grayson W. Stowell, Paul Menkin
  • Publication number: 20120014999
    Abstract: Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2/g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a drug such as insulin.
    Type: Application
    Filed: June 11, 2010
    Publication date: January 19, 2012
    Inventors: Marshall L. Grant, Grayson W. Stowell, Paul Menkin
  • Patent number: 5998237
    Abstract: A permanent curable photosensitive liquid dielectric polymer composition is disclosed for making copper printed circuit boards having at least one photosensitive dielectric polymer layer containing vias and circuitry thereon wherein the polymer layer has enhanced copper to dielectric adhesion. The dielectric composition preferably comprises an acrylated epoxy and a metal adhesion effective amount of amorphous silica. Printed circuit boards made using the photodefinable dielectric polymer and a method for making the printed circuit boards are also disclosed. A twice performed permanganate etching process for texturing the dielectric surface is also preferably used to further enhance the copper to dielectric adhesion.
    Type: Grant
    Filed: September 17, 1996
    Date of Patent: December 7, 1999
    Assignee: Enthone-OMI, Inc.
    Inventors: Jay B. Conrod, Van K. Chiem, Paul Menkin
  • Patent number: 5368718
    Abstract: A specially controlled electrolytic process for regenerating for reuse solutions such as the post activator solution used in the direct metallization process for making printed circuit boards is disclosed whereby the contaminant tin level of the operating solution is controlled at desired levels.
    Type: Grant
    Filed: September 13, 1993
    Date of Patent: November 29, 1994
    Assignee: Enthone-OMI, Inc.
    Inventors: Jay B. Conrod, Paul Menkin, Durand A. Cercone
  • Patent number: 5181770
    Abstract: An electrolyte solution for the electroforming of metal foil, such as copper, is provided. The electrolyte contains an effective concentration of chloride ions to promote the formation of a uniformly matte surface finish. Foil so formed forms a strong mechanical bond with a dielectric substrate during a subsequent lamination process.
    Type: Grant
    Filed: June 11, 1990
    Date of Patent: January 26, 1993
    Assignee: Olin Corporation
    Inventors: Andrew J. Brock, Lifun Lin, Paul Menkin, Ned W. Polan
  • Patent number: 5071520
    Abstract: A technique for improving the peel strength of copper and copper based alloy materials, and particularly for copper or copper based alloy materials which may be wrought or electrolytically deposited copper foil having an antitarnish treatment applied thereto, preferably by the use of a chromate-containing solution. The material is subjected to a rinse containing a silane coupling agent, which preferably is an organofunctional silane, and more preferably is an alkoxysilane derivative. Both the original peel strength and the peel strength after storage of the material so treated is enhanced.
    Type: Grant
    Filed: October 30, 1989
    Date of Patent: December 10, 1991
    Assignee: Olin Corporation
    Inventors: Lifun Lin, Paul Menkin
  • Patent number: 4956053
    Abstract: A process and apparatus for producing metal foil comprises supplying an isotopically polished continuous cathode, a high volume turbulent flow of electrolyte and rigorous filtration to exclude chlorides, sulfides, organics and other impurities from the electrolyte. The foil so produced is free from micro-voids and able to withstand substantially higher biaxial stresses than conventional electrodeposited foil. The micro void free structure also decreases the diffusion rate of an underlying substrate.
    Type: Grant
    Filed: September 21, 1989
    Date of Patent: September 11, 1990
    Assignee: Olin Corporation
    Inventors: Ned W. Polan, Raymond J. Smialek, Paul Menkin